杭州民生药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
218
NMPA:218
Drug Approvals
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20254346
- Approval Date
- May 27, 2025
NMPA
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20254326
- Approval Date
- May 27, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20254162
- Approval Date
- May 13, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20254161
- Approval Date
- May 13, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20254160
- Approval Date
- May 13, 2025
NMPA
Ursodeoxycholic Acid Capsules
- Product Name
- 熊去氧胆酸胶囊
- Approval Number
- 国药准字H20253683
- Approval Date
- Mar 25, 2025
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20253270
- Approval Date
- Jan 24, 2025
NMPA
Multiple Electrolytes Injection（II）
- Product Name
- 复方电解质注射液(Ⅱ)
- Approval Number
- 国药准字H20253260
- Approval Date
- Jan 24, 2025
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20253269
- Approval Date
- Jan 24, 2025
NMPA
Pilocarpine Nitrate Eye Drops
- Product Name
- 硝酸毛果芸香碱滴眼液
- Approval Number
- 国药准字H20058779
- Approval Date
- Sep 25, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 22
- Next
Clinical Trials
No trials found
News
No news found